Loading…
Sulzer Ltd agreed to acquire Swiss-German drug delivery device developer and manufacturer Haselmeier for an enterprise value of EUR 100 million, to complement its Applicator Systems business.
Haselmeier and Stevanato Group announced an exclusive agreement to license the Axis-D pen-injector technology and IP for diabetes care. Stevanato Group will manufacture the device at its facilities.